智通财经APP获悉，十一国庆节前夕港股医药板块强势反弹，艾美疫苗(06660)连续领涨，今日早盘一度涨超25%。截至发稿，涨18.04%，报6.87港元，成交额8775.66万港元。
消息面上，艾美疫苗发布公告，公司在研迭代无血清狂苗Ⅲ期临床试验数据已完成揭盲及统计分析工作，结果显示该疫苗具有良好的免疫原性和安全性，达到临床预设目标。截至目前，全球尚没有无血清狂苗上市，该产品有望成为首个上市产品，引领行业技术深度迭代升级。
据悉，迭代无血清狂苗，与目前含有血清的Vero细胞狂苗和含有血清的人二倍体狂苗完全不同，因为不含有动物血清，显著提高了安全性，降低了不良反应的概率，让接种者更安全，是一款重磅创新的迭代升级产品。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.